Thursday, September 16

Health will reach 70% immunity in three weeks thanks to the extra supply of vaccines

After a month of July in which the number of doses administered was reduced compared to June, August seems to be key to vaccinating the bulk of the population, especially young people, which is the population group in which they are concentrating the most infections at this time in the fifth wave of the pandemic. Furthermore, the Community has lagged behind in immunizing the segment of the population between 30 and 39 years, with 15% of people who have received the complete guideline, very far from the 38.5% that is registered on the national level on average. A situation that can take a turn as of next week when the extra doses of vaccines begin to arrive.

First consignment

The Council of Ministers has already approved the acquisition of these 3.4 million extra doses, of which 340,000 correspond to the Community Valencian. The first batch of 1.1 million injectables, 110,000 for our autonomy, will arrive at the end of this week to be able to be administered in the next. Vaccines that are added to the 244,000 of the Moderna laboratory that the Government has promised to send to the Community to compensate for the vaccination of people from other autonomous communities.

Extra vaccines that will make it possible to advance the threshold of 70% of vaccinated, although Puig did not want, to questions from journalists, to enter to assess whether this percentage is sufficient to deal with the Delta strain, much more transmissible than the previous ones. Experts estimate that in the face of this variant, which already colonizes almost one hundred percent of the Valencian Community and with the same transmission power as chickenpox, vaccination coverage of at least 85% is necessary so that there is no circulation of the virus.

“In August it will reach 70% and from there we will begin with the vaccination of minors and we hope that by the beginning of the year all schoolchildren can be vaccinated,” said Puig. The president of the Consell has reiterated that the objective is that on October 9 the Valencian Community “Be immune.”

Asked if the Valencian Community is going to choose as in Andalusia to require the vaccination card or a test to access leisure venues, Puig has insisted once again that this measure is not going to be applied until the entire world has had the opportunity to be vaccinated. However, he believes that it is an “interesting option to study when everyone has the option to be vaccinated” as a way to encourage “everyone to get vaccinated and help the entertainment and entertainment sector.” Meanwhile, he added, “it is somewhat discriminatory because it has not yet been possible to offer everyone the opportunity to get vaccinated.”


On possible relief from restrictions facing this month of August, the president has insisted that “still at a time of maximum alert and prudence.” Puig maintains that at the moment in the Valencian Community there is much more population due to the summer holidays, “doubling and tripling” in some areas. An increase in population “that generates a lot of mobility that generates many infections.” The message that Puig launches “is that the pandemic has not passed, it is among us, there are many young people who are infected because they do not have the complete pattern and it also affects people who have the complete pattern although to a lesser extent.”

The Valencian Community maintains the restrictions until July 16 due to the advance of the fifth wave of the coronavirus. Among them, el curfew in 17 municipalities of the province of Alicante between 1 and 6 in the morning: Alfàs del Pi, Alicante, Banyeres de Mariola, Benidorm, Callosa dEn Sarrià, Callosa de Segura, Calp, Dénia, Gata de Gorgos, La Nucía, Muro de Alcoy, Ondara, Pego, Santa Pola, Sax, Teulada and Vila Joiosa.

Health coordinates a platform to study the effectiveness of vaccines

The Vaccine Research Area (AIV) of the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio) coordinates the so-called Covidrive, an international project that will estimate the effectiveness of vaccines against covid-19 in Europe and that starts this month. “Covidrive will provide essential information when designing vaccination programs for covid in Europe and will allow pharmaceutical companies to provide the vaccine effectiveness data required by regulatory agencies,” explains Antonio Carmona, AIV researcher and scientific coordinator of the project .

Leave a Reply

Your email address will not be published. Required fields are marked *